Nanobiotix Analyst Price Targets - Benzinga

Nanobiotix SA

NBTXNASDAQ

Trade with Public

Trade with Public

$31.37

-2.43-7.19%

Dern. MÀJ: Oct 30, 7:57 AM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Comparer Options Rapport sur les stocks

Nanobiotix Analyst Price Targets

Wall Street analyst price targets and consensus rating for Nanobiotix (NBTX).

Price Target Range — 6 Quarters

Analyst Consensus — 3 Analysts

2Buy

1Hold

Consensus RatingBuy# Analysts3Avg. Consensus PT$44Upside to Avg. PT+34.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 15, 2026	Guggenheim	Paul Jeng	Assumes	Buy	$64
Jun 4, 2026	Leerink Partners	Jonathan Chang	PT Raise	Outperform	$37→$46
May 1, 2026	UBS	Colin Bristow	PT Raise	Neutral	$4→$30
Apr 2, 2026	Guggenheim	Michael Schmidt	PT Raise	Buy	$26→$36
Feb 6, 2026	Guggenheim	Michael Schmidt	PT Raise	Buy	$8→$26
Apr 4, 2025	Guggenheim	Michael Schmidt	PT Cut	Buy	$12→$8
Aug 28, 2024	Guggenheim	Michael Schmidt	Initiate	Buy	$12
Dec 8, 2023	Leerink Partners	Jonathan Chang	Initiate	Outperform	$11

Analyst Ratings News

PRO
Guggenheim Assumes Nanobiotix at Buy, Announces Price Target of $64

Guggenheim analyst Paul Jeng assumes Nanobiotix (NASDAQ:NBTX) with a Buy rating and announces Price Target of $64.

Benzinga Newsdesk

PRO
Leerink Partners Maintains Outperform on Nanobiotix, Raises Price Target to $46

Leerink Partners analyst Jonathan Chang maintains Nanobiotix (NASDAQ:NBTX) with a Outperform and raises the price target from $37 to $46.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $36

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $26 to $36.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $8 to $26.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Nanobiotix, Lowers Price Target to $8

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and lowers the price target from $12 to $8.

Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On Nanobiotix with Buy Rating, Announces Price Target of $12

Guggenheim analyst Michael Schmidt initiates coverage on Nanobiotix (NASDAQ:NBTX) with a Buy rating and announces Price Target of $12.

Benzinga Newsdesk